• Latest Posts

This Herpes Cure is Proving to Work Better than its Predecessors

An Antibody to reduce Hospitalizations of Children starts Phase IIb trials

Phase II Failure: CureVac’s CEO explains Missed Efficacy Endpoint

Cold Sore Cure Company enters the Antibiotic Resistance fight

Bacteria can Protect each other: a New Challenge in Antibiotic Resistance

ADVERTISEMENT

How Will Biotech Overcome the Huge Challenges of Microbial Resistance?

French Biotech Puts a New Lyme Disease Vaccine on the Horizon

With a new €120M Infusion, Pocket NGS CEO talks Success and Strategy

UPDATE: The HIV Frontier starts Phase III Vaccine trials in South Africa

Finally a Cure for the Common Cold? And it’s Needle-free!

Microfluidics and Biosensors to tackle Antibiotic Resistance

ADVERTISEMENT